Skip to content

Zero-ischemia Robot-assisted Partial Nephrectomy Using Near-infrared Fluorescence

Zero-ischemia Robot-assisted Partial Nephrectomy Using Near-infrared Fluorescence: A Prospective, Monocentric, Randomized, Comparative and Open-label Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03679572
Acronym
EMERALD
Enrollment
31
Registered
2018-09-20
Start date
2018-02-05
Completion date
2020-12-01
Last updated
2020-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cancer

Keywords

partial nephrectomy, robot-assisted, surgery, near-infrared fluorescence, ischemia

Brief summary

Patients with renal cancer are commonly treated by robot-assisted partial nephrectomy. Renal artery clamping is commonly required inducing kidney ischemia during surgery. It impacts parenchymal and renal function. This study aims to compare a new surgical procedure in order to reduce ischemia effect and preserve renal function after partial nephrectomy for renal tumour.

Interventions

PROCEDURERobot assisted partial nephrectomy super-selective clamping

The device used to performe the surgery is a Da Vinci robot. After injection of infracyanine, the super-selective clamping is possible. The surgery is performed using a specific clamping of the tumor arteries. Super-selective ischemia is checked using near infrared fluorescence.

PROCEDURERobot assisted partial nephrectomy with renal artery clamping

Partial nephrectomy is performed with the conventional method in wich a renal artery clamping is done.

Sponsors

Clinical Investigation Centre for Innovative Technology Network
CollaboratorNETWORK
Intuitive Surgical
CollaboratorINDUSTRY
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* candidate for a robot-assisted partial nephrectomy for renal tumour * patient affiliated to social security * signature of the informed consent

Exclusion criteria

* proven or suspected allergy to the indocyanine green * coagulation disorder contraindicating robot assistance in the partial nephrectomy * medical pathology contraindicating pneumo-peritoneum * multiple tumors * horseshoe kidney * exclusion period of another interventionnal study * protected person referred to in Articles L1121-5 to L1121-8 of the Code of Public Health

Design outcomes

Primary

MeasureTime frameDescription
Benefit on postoperative renal function of fluorescence-enhanced super-selective clamping during robot assisted partial nephrectomy compared with robot-assisted partial nephrectomy with renal artery clamping6 monthsThe glomerular filtration rate (GFR) of the kidney operated is assessed at 6 months after surgery. This value is compared to that assessed before the surgery to see the variation. This variation is compare between the two groups.

Secondary

MeasureTime frameDescription
Surgical duration in the two groups6 monthsDuration between the first incision and the skin closure
Complications1 monthnumber of complications per and post-surgery up to 1 month
Per-surgery blood loss1 monthper-surgery blood loss in millimeter
Number of group conversion in the zero ischemia method.6 monthsThe feasibility of the new technique is assessed by counting the number of group conversion towards conventional technique.
Positive surgical margins1 monthNumber of positive surgical margins
Variation between global GFR in the two groups6 monthsThe variation of the global GFR is assessed after surgery, when patient is discharged. This value is compared to the that collected before the surgery.
Renal parenchyma preserved6 monthsThe percentage of renal parenchyma preserved is evaluated by CT renal volumetry at 6 months after the surgery. The value is compared to that collected before the surgery.
Hemoglobine rate variation1 monthFor patients having no received blood transfusion, the hemoglobine rate variation is assessed in percentage at one month in post-surgery.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026